Research Institute Diabetes Academy Mergentheim, Bad Mergentheim, Germany.
Diabetes Center Mergentheim, Bad Mergentheim, Germany.
J Diabetes Sci Technol. 2024 Sep;18(5):1000-1003. doi: 10.1177/19322968241271925. Epub 2024 Aug 19.
The last 25 years of CGM have been characterized above all by providing better and more accurate glucose values in real time and analyzing the measured glucose values. Trend arrows are the only way to look into the future, but they are often too imprecise for therapy adjustment. While AID systems provide algorithms to use glucose values for glucose control, this has not been possible with stand-alone CGM systems, which are most used by people with diabetes. By analyzing the measured values with algorithms, often supported by AI, this should be possible in the future. This provides the user with important information about the further course of the glucose level, such as during the night. Predictive approaches can be used by next-generation CGM systems. These systems can proactively prevent glucose events such as hypo- or hyperglycemia. With the Accu-Chek® SmartGuide Predict app, an integral part of a novel CGM system, and the Glucose Predict (GP) feature, people with diabetes have the first commercially available CGM system with predictive algorithms. It characterizes the CGM systems of the future, which not only analyze past values and current glucose values in the future, but also use these values to predict future glucose progression.
过去 25 年的 CGMS 主要特点是提供更好和更准确的实时血糖值,并分析测量的血糖值。趋势箭头是预测未来的唯一方法,但它们通常对治疗调整来说不够精确。虽然辅助胰岛素输注系统(AID)提供了使用血糖值进行血糖控制的算法,但独立的 CGMS 系统却无法做到这一点,而独立的 CGMS 系统是糖尿病患者最常使用的系统。通过使用算法(通常由人工智能支持)分析测量值,未来应该可以实现这一点。这为用户提供了关于血糖水平进一步发展的重要信息,例如在夜间。下一代 CGMS 系统可以使用预测方法。这些系统可以主动预防低血糖或高血糖等血糖事件。Accu-Chek® SmartGuide Predict 应用程序是新型 CGMS 系统的一个组成部分,它具有血糖预测(GP)功能,是首款具有预测算法的商业化 CGMS 系统。它是未来 CGMS 系统的特征,这些系统不仅分析过去的值和未来的当前血糖值,还使用这些值来预测未来的血糖进展。